Chemokines And Growth Factors As Key Mediators Of Immunoangiogenic Mechanisms In Uterine Fibroids (Review Paper)
DOI:
https://doi.org/10.62480/tjms.2025.vol49.pp1-11Keywords:
uterine fibroids, leiomyoma, chemokinesAbstract
This review systematizes current data on the role of chemokines (CXCL8, CXCL10, CCL2, CCL3, CCL4, CCL5) and growth factors (VEGF-A, TGF-β1/β2, EGF, FGF2) in the immuno-inflammatory and angiogenic mechanisms underlying the pathogenesis of uterine fibroids. It is shown that elevated levels of these mediators promote the activation of macrophages, T-lymphocytes, and endothelial cells, thereby enhancing angiogenesis and stromal fibrosis. The imbalance between pro-inflammatory and angiostatic cytokines forms a microenvironment that supports the growth and recurrence of fibroid nodules. The summarized data confirm the pivotal role of chemokines and growth factors as pathogenetic determinants and potential biomarkers of leiomyoma activity, opening new prospects for the development of targeted and immunotherapeutic strategies in gynecology
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
User Rights
Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).
Rights of Authors
Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.









